A campaign to tackle the particular problems posed by rare cancers was launched this summer. European Action Against Rare Cancers (www.rarecancers.eu) is determined to put this neglected set of diseases firmly on the European health [more]
Working at a massive hospital in a country with high rates of advanced women’s cancers gave Vesna Kesic the ideal opportunity to hone her skills as a gynaecological oncology surgeon. Thanks to her commitment to [more]
Many breast cancer therapies affect a woman’s chances of having a child in the future. A growing body of literature is beginning to throw some light on the impact of different treatment options. How can [more]
The story of step-by-step progress, with occasional leaps forward and frequent setbacks, is not one the media enjoys telling. But it does need to be told if patients and society are to learn to live [more]
There was a time when the International Union Against Cancer (UICC) was not so international being focused primarily on Western countries and not so much of a union lacking the ability to [more]
A conversation with health journalists Download full article
When stories exaggerate the implications of the latest research, is this the fault of the media? Asession on reporting cancer breakthroughs found pressure also comes from researchers and pharmaceutical companies. Maybe the greatest pressure comes [more]
When it comes to prevention, screening, treatment and coping with the experience of cancer, the media can play an important role in equipping people to make the best possible choices. At an ESO workshop at [more]
Imatinib is known to be effective in the first-line treatment of metastatic gastrointestinal stromal tumours. A randomised, placebo-controlled trial has now shown that imatinib is safe and improves recurrence-free survival when used as adjuvant therapy [more]
Pelvic lymphadenectomy offers no therapeutic benefit to women diagnosed with early-stage endometrial cancer according to a new study. Lymphadenectomy can only be recommended as part of a clinical trial in this disease setting; however, it [more]
Selected reports edited by Janet Fricker Download full article